Inhalon Biopharma
Edit info- Founded: 2018
- Location: Morrisville, NC
- Employee range: 1 - 10
- Clinical stage: Clin1
- Therapy area: COVID-19
- Drug types: INF
- Lead product: IN-006
- Funding: 10-100M
inhalon.com linkedin.com job board
Business:
Biologics
Drug notes:
IN-002 Clin0 RSV; undisclosed RD metapneumovirus; undisclosed RD parainfluenza
About:
Inhalon Biopharma is a clinical-stage biotechnology company developing revolutionary inhaled antibody treatments for acute respiratory infections (ARIs). The company's unique science is based on its proprietary muco-trapping antibody platform, which targets and binds viruses and bacteria in mucus, the protective lining of the airways. This innovative approach enables direct and localized treatment of respiratory infections, potentially preventing the spread of pathogens and reducing the severity of symptoms.
Jobs:
News:
Inhalon Biopharma Announces Two Publications Advancing its Inhaled Antibody Treatment Platform for Acute Respiratory Infections - Business Wire
googlenews
Mar 14, 2024
Science/business updates
external-link
Celltrion races inhaled COVID-19 antibody therapy into phase 3 to counter omicron - FiercePharma
googlenews
Feb 7, 2022
Science/business updates
external-link
Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development ...
crunchbase
Nov 15, 2023
Funding-related
external-link
Celltrion's Inhaled COVID-19 Treatment Found Safe In Clinical Trial - TBS뉴스
googlenews
Feb 7, 2022
Science/business updates
external-link
Regkirona deals signed with 18 countries by Celltrion Healthcare - The Korea JoongAng Daily
googlenews
Dec 9, 2021
Science/business updates
external-link
Methods and apparatuses for delivery of an agent to the lungs and nasal …
crunchbase
Aug 16, 2022
Science/business updates
external-link
Compositions and methods for inhalable therapeutics
crunchbase
May 23, 2023
Science/business updates
external-link
Inhalon Biopharma Announces Two Publications Advancing its Inhaled Antibody Treatment Platform for Acute ...
crunchbase
Mar 17, 2024
Science/business updates
external-link
Celltrion bags European approval for COVID-19 antibody treatment - BioWorld Online
googlenews
Nov 16, 2021
Science/business updates
external-link
View page
web
Jan 2, 2025
I don't have enough information to classify this title. The title "View page" doesn't provide any meaningful content. Can you provide a real news title?
external-link
Inhalon Biopharma licenses hMPV antibodies from University of Georgia
crunchbase
Nov 2, 2023
Science/business updates
external-link
UNC spin-out targeting lung disease looks to raise millions
crunchbase
Mar 21, 2024
Funding-related
external-link
Meet Bhawana Shrestha, Microbiologist Who Has Engineered Sperm-Killing Antibodies To Prevent Pregnancy - SheThePeople
googlenews
Sep 30, 2021
Science/business updates
external-link
Celltrion`s inhaled Covid-19 therapy proven safe in Phase 1 clinical trial - 매일경제
googlenews
Feb 8, 2022
Science/business updates
external-link
Durham biopharma lands $7M to develop ‘muco-trapping’ antibody platform
crunchbase
May 26, 2021
Funding-related
external-link
Inhalon Biopharma Announces Positive Results from Study Demonstrating Superior Safety and Efficacy of its Inhaled ...
crunchbase
Mar 24, 2024
Science/business updates
external-link
Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19 - BioSpace
googlenews
Oct 7, 2021
Science/business updates
external-link
© 2025 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com